Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RG - Hopefully underpromising and hoping to overdeliver

RG - Hopefully underpromising and hoping to overdeliver

posted on Feb 10, 2009 11:12AM

When you look at the presentation he gave at the FSX conference, MMP still plays a key roll, even though he may be underemphasizing it in the SH Letters. For example, slide 6 titled "Key Objectives" shows the following:


•Expand MMP™ patent licensees
–Exclusively through The TPL Group (Alliacense)

•Leverage IP licensing proceeds for future growth
–M&A opportunities in data sharing software (use cash/stock)
–Strategic investments (early stage data sharing technologies)

•Enhance long term shareholder value
–Build a company with revenues/profits in growth markets
–Increase PE on future MMP earnings
–Increase institutional funds investor base (US and Europe)
–Pursue listing on more broadly traded exchange


Check it out here.

http://www.ptsc.com/images/fsx_confe...

Share
New Message
Please login to post a reply